Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRDS | Common Stock | Conversion of derivative security | $0 | +4.87M | $0.00 | 4.87M | Dec 23, 2021 | Direct | F1 | |
holding | PRDS | Common Stock | 603K | Dec 23, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PRDS | Common Stock | Conversion of derivative security | $0 | -4.87M | -100% | $0.00* | 0 | Dec 23, 2021 | Common Stock | 4.87M | $0.00 | Direct | F1 |
FS Development Holdings II, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | In connection with the closing of Pardes Biosciences, Inc.'s (formerly known as FS Development Corp. II) business combination, shares of Class B Common Stock of FS Development Corp. II converted into common stock of the Issuer. |